← All trials
NCT02273830
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2015
- Primary completion
- Oct 1, 2017
- Completion date
- Oct 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 112
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Hospital de GranollersLead sponsor
- Hospital de GranollersOverall official - principal investigator
- Hospital de GranollersSponsor investigator
- Hospital Mutua de TerrassaCollaborator
- University of BarcelonaCollaborator
- Hospital Dos de MaigCollaborator
- Rovira i Virgili UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.